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DNA…"This structure has novel features which are of considerable biological interest”  
Watson JD, Crick FH. 1953 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To my family, 
 
“A mi familia terrenal y celestial” 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Too… 
I would like to dedicate my thesis to the victims of the Colombian Conflict. I pray that one 
day not too far in the future, my homeland (Colombia) and other regions in the world that 
currently suffer from war can live in peace. I am also hopeful that one day every child has the 
opportunity to go to school as was afforded to me. 
 
 
 “One child, one teacher, one book and one pen can change the world. Education is the only 
solution. Education first.” 
Malala Yousafzai (2014 Peace Nobel Prize)  
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ABSTRACT 
In this thesis we have studied two different types of molecules that bind to the major groove 
of the DNA: (i) oligonucleotides (ONs) containing locked nucleic acid (LNA) and in 
combination with intercalating agents (Twisted Intercalating Nucleic Acid, TINA, and 
Benzoquinoquinoxaline, BQQ) and (ii) peptides mimicking the leucine zipper transcription 
factor (GCN4 bZIP TF). Both ONs and peptides bind to the DNA double helix aiming to 
serve as transcription regulators of disease related genes. In paper I, we developed a clamp 
type LNA ON (bisLNA) having the capacity to invade and bind double-stranded supercoiled 
DNA, as demonstrated by chemical probing. BisLNA has a dual mode of binding to duplex 
DNA, by Hoogsteen interactions forming a triplex structure and by double strand invasion 
(DSI) forming new Watson-Crick hydrogen bonds. Optimization of the bisLNA construct 
was carried out in particular regarding the number and location of LNA nucleotides and the 
length of the triplex-forming and the strand-invading arms, and we achieved 30% DSI using 
plasmid DNA. In paper II, by combining EMSA and molecular dynamics (MD) simulations 
we evaluated the structural features of modified ONs in stabilizing both duplex and triplex 
structures; we found that reduction in the LNA content at the 3’-end of a triplex forming 
oligonucleotide (TFO) destabilized the triplex. Moreover, we demonstrated that positioning 
TINA at the 3’-end of a TFO had an advantageous effect on triplex stability, and BQQ was 
able to stabilize the pyrimidine motif triplex containing LNA ON and TINA. MD simulation 
showed that LNA-substitution in the pyrimidine strand of a duplex alters the double helix 
structure, changing x-displacement, slide and twist allowing triplex formation through 
enhanced TFO major groove accommodation. Finally, we also elucidated the mechanism of 
bisLNA binding to a dsDNA, which basically involves a two-step process where the triplex is 
formed first followed by double strand invasion. Finally, in paper III, four models of the 
GCN4 bZIP TF were evaluated, but only one achieved high sequence specific dsDNA 
binding as was demonstrated by electrophoretic mobility shift assay (EMSA) and the 
obtained dissociation constant. The same peptide showed a better uptake when evaluated in 
macrophages, demonstrating the potential of peptide-steroid based TF mimics. 
In summary, the results provide a basis for further development of DNA binding chemical 
compounds, which could potentially have future applications in medicine and biotechnology 
in the future. 
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1 INTRODUCTION 
 
1.1 OVERVIEW OF DNA 
In 1865 Gregor Mendel described the fundamental laws of inheritance and deduced that 
genes come in pairs and are inherited as distinct units, one from each parent (1). A few years 
later, Friedrich Miescher, was interested in the chemistry of cells and discovered a chemical 
substance “nuclein” isolated from the cell nuclei of white blood cells, that he described as a 
substance high in phosphorus and later known as nucleic acid (2,3); one of his collaborators, 
Kossel determined the chemical composition of the nucleic acid describing the nucleobases: 
adenine, cytosine, guanine, thymine and uracil (4). At the same time Phoebus Levine 
discovered the carbohydrate compound of RNA (ribose) and DNA (deoxyribose), and the 
chemical composition of a single nucleotide (phosphate-sugar-base) (5,6). In the 1940s, 
Avery and his colleagues based on the analysis of Griffith´s work about DNA as the 
"transforming principle" (7), demonstrated that the DNA was the hereditary material by using 
two types of Pneumococcus strains: smooth (S) that are encapsulated, and rough (R); they 
treated the S-strain with enzymes (protease, RNase and DNase) and mixed with R-form  
Pneumococcus, and observed that after treatment the S-strain appeared in all of the cultures, 
except in the cultures where the S-strain that was treated with DNase (8). A few years later 
Chargaff isolated DNA from different organisms, measured the four nitrogen bases and 
demonstrated that the total amount of purine and pyrimidine are usually nearly equal, but that 
their percentage and the amount of DNA varies between species (9). It was in the beginning 
of the 1950s when Rosalinda Franklin, using X-ray crystallography, determined the 
“signature” of the DNA and thereby provided information about the shape and structure and 
calculated the basic dimensions (10,11). Based on this information, in 1953 James Watson 
and Francis Crick proposed the structure of the DNA, a double helix with the phosphate 
groups located on the outside and the bases inside, with specific pairing of purine with 
pyrimidine nucleobases through complementary hydrogen bonds (12). This model remains 
valid and became accepted and set the basis for the revolution of studies aimed at 
understanding the activity of nucleic acids and their role in the living cells as carriers of the 
genetic information (13). Finally, the crystal structure of the most common form, the B-type 
of DNA, was solved using heavy atom X-ray crystallography in the 1980s (14,15). 
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1.2 DNA STRUCTURE  
1.2.1 Base-pairing 
1.2.1.1 Watson-Crick base-pairing (WC) 
Formation of WC hydrogen bonds is the more common interaction between bases. The two 
strands of the double helix are connected by hydrogen bonds. In DNA Adenine binds to 
Thymine, and Cytosine to Guanine (13).  
1.2.1.2 Hoogsteen base-pairing (HG) 
Hoogsteen hydrogen bonds are responsible for the specificity and stability of the triplex 
structure (16,17). Due to that purines contain an available position to form hydrogen bonds, it 
is possible to hybridize a third strand to purine-rich sequences, forming a triplex by binding in 
the major groove of the DNA (18). In addition HG base pairing plays an important role in 
stabilizing several non-B DNA conformations (described in section 1.2.3). 
 
Figure 1. Hoogsteen base pairing in triplex structures. 
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1.2.2 Double strand invasion (DSI)  
Double strand invasion (DSI) can occur when an ON displaces one of the DNA strands 
forming new WC hydrogen bonds with the other strand. Different modes of DSI binding have 
been described and a summary is presented below at the section of nucleic acid analogs. 
1.2.3 DNA conformations 
By oversimplifying the thermodynamic factors associated with helix formation of DNA it is 
possible to say, that the enthalpy of interstrand hydrogen bonds, base stacking and free water 
molecules are favorable for helix formation. Contrary, the entropy of free bond rotations, free 
translation/rotation and hydrogen bonds to water are unfavorable (19). Thus, DNA can adopt 
different conformations depending on the base sequence and environment (20). The most 
studied conformations of the double helix are three: A, B and Z. Table 1 summarizes of the 
helical parameters for A-DNA, B-DNA and Z-DNA. 
A-DNA is a right-handed antiparallel double helix that appears in x-ray diffraction studies 
when the relative humidity is reduced to less than about 75% and is rarely observed under 
physiological conditions (21). 
The B-DNA conformation was proposed by Watson and Crick in 1953 (12,13). B-DNA is a 
right-handed antiparallel helical duplex and is the most prevalent form of DNA in living cells 
(22).  
Z-DNA (unlike A- and B-DNA) is the only known left-handed form of the double helix and 
is called Z, because the phosphate groups make a zigzag along the backbone (23). Z-DNA 
was discovered in 1979 (24), and was the first DNA structure determined by crystallography. 
Its physiological role mainly remains elusive and it was not until many years later that its role 
in viral infections was deciphered (25).  
Table 1. Helical parameters 
 A-DNA (21) B-DNA (22) Z-DNA (24) 
Twist 
Rise 
Roll 
Inclination 
χ-Displacement 
Propeller twist 
33° 
2.56 Å 
6.0° 
21° 
-4.5 Å 
-7.5 
36° 
3.38 Å 
0° 
-6.0° 
0.23 Å 
-4.4° 
-30° 
3.7 Å 
0° 
-6.2° 
3.0 Å 
-4.4° 
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Figure 2. The duplex 3D structures. The A, B, Z type helixes with 17-mer sequences are 
shown in front and top views. The structures were generated using w3DNA (26). (Structures 
courtesy of You Xu) 
Moreover, DNA has the capability to adopt a variety of non-canonical structures (Non B-
form secondary structures) (27): G-quadruplex (28), cruciform, hairpin and triplex, etc. The 
non-B DNA structure-forming sequences can induce genetic instability and consequently be 
the cause of human diseases (29-33), some of these structures are present in genomic regions 
as in expanded number of copies of simple repeats, which are associated with neurological 
diseases (34-37). The formations of those structures are highly favorable by the enthalpy but 
highly unfavorable by the entropy in aqueous solutions (19,38,39).  
1.3 DNA TRIPLE HELIX (DNA TRIPLEX) 
Linus Pauling was the first to propose the formation of a triple-strand helix structure for DNA 
(40,41). However, it was only four years after Watson and Crick published their seminal 
paper in the Nature journal about the DNA structure (12), that Felsenfeld et al. discovered 
that RNA can form triple helices (42). This type of binding was sequence specific and 
stabilized by divalent cations. Later on, in 1968 it was shown that an RNA-dsDNA triplex 
can form and inhibit transcription (43).  Triple helix structures of nucleic acids (DNA and 
RNA) can be divided into: intermolecular and intramolecular triplexes (44) (45) .   
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1.3.1 Intermolecular triplexes 
Felsenfeld et al. described the first triple helix in polyribonucleotides formed in the presence 
of Mg2+ (42). Intermolecular triplexes are formed when the third strand originates from 
another DNA molecule (45). The third strand ON recognizes oligo-purine sequences and 
binds the dsDNA in the major groove forming hydrogen bonds (46,47). Those types of ONs 
are known today as triple helix forming oligonucleotides or triplex forming oligonucleotides 
(TFOs). Intermolecular triplexes form with a pyrimidine third strand (Y:RY), a purine third 
strand (R:RY) or mixed pyrimidine/purine third strand. In this thesis we focused on 
intermolecular triplexes. Table 2 summarizes the characteristics of the different triplex helix 
motifs.  
The formation of triplexes under physiological conditions is a process with slow kinetics 
when compared with the formation of a duplex (48-52), but once triplexes are formed, they 
are stable and have half-lives of days (48,50,51).  
Transcription can be inhibited by TFOs as a consequence of two different mechanisms 
(53,54): (i) inhibiting transcription initiation by competing with transcription factor binding 
(55) or (ii) arresting transcription elongation by binding further downstream in the transcribed 
gene (56). 
Table 2. Triple helix classification 
Motif Characteristics 
 
Py motif: (T, C) (G, T) (T, C, G) 
 
The third strand binds parallel (5’-3’) to the purine 
strand by Hoogsteen hydrogen bounds 
Protonation of cytosine (N3) is required for 
Hoogsteen bonding with guanine (N7) 
Acidic conditions are required 
 
Pu motif: (G, A) (G, T) (G, A, T) (G, T, A) 
  
Third strand binds antiparallel (3’-5’) to the purine 
strand by reverse Hoogsteen hydrogen bonds 
No required protonation 
Essentially pH independent 
Pu, purine. Py, pyrimidine. TFO (yellow), polypurine strand (red), polypyrimidine strand (blue). () 
indicates HG hydrogen bonds and (I) indicates WC hydrogen bonds. 
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1.3.2 Intramolecular triplexes 
In 1987 Mirkin discovered the intramolecular triplex structure in plasmid DNA at low pH 
(57,58). Intramolecular triplexes are also called H-DNA (59). In intramolecular triplexes the 
third strand originates from one of the strands of the same double helix DNA that contains a 
mirror repeat sequence. These triplexes can form different structures depending on their 
triplex structural motifs (60), if the third strand is Py-rich (H-DNA)(59), and if the third 
strand is Pu-rich (*H-DNA)(61).  
1.4 NUCLEIC ACID ANALOGS 
The requirements for an optimal TFO are: high affinity binding to the dsDNA target at 
physiological pH and salt conditions, sequence specificity and resistance to degradation by 
endonucleases. One way to achieve these requirements is by introducing modifications to the 
base, the sugar or the backbone portion of the DNA or RNA. Modified ONs, including 
peptide nucleic acid (PNA) or locked nucleic acid (LNA) have been developed and used in 
the anti-gene to target dsDNA. 
1.4.1 Locked nucleic acid (LNA)   
Locked nucleic acid (LNA) is a nucleic acid modification developed in the late 1990s by two 
independent groups, one in Denmark and the other in Japan (62,63). LNA contains a 
methylene bridge connecting the 2´-oxygen with the 4´-carbon in the furanose ring. The 
bridge locks the sugar moiety in an N-type sugar ring conformation providing enhanced 
hybridization properties. Due to this conformation, the backbone of LNA is reorganized as a 
consequence of base stacking (64); another effect of the locked conformation is the increase 
in melting temperature (2-8°C) per nt (65). Moreover, NMR studies of duplexes containing 
LNA confirmed that LNA appears as an RNA-analogue (66,67). New LNA chemistries have 
provided different analogues with new properties such as, 2’-amino-LNA (68), α-L-LNA 
(69) and ethylene-bridged nucleic acid (ENA) (70) among others. 
Various LNA chemistries have been used in TFOs (71-78), clamp ONs (79-81), invader-
LNAs (82) and Zorro-LNAs (83-86), as anti-gene reagents (87) to block transcription, and in 
antisense approaches (87) to induce RNA degradation by RNase H, to increases the stability 
of small interfering RNA (siRNA) (88),  to alter pre-mRNA splicing, as anti-mirRs (89). 
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Figure 3. Chemical structure of locked nucleic acid (LNA), 2’-amino-LNA, α-L-LNA and 
ethylene-bridged nucleic acid (ENA) 
1.4.2 Peptide nucleic acid (PNA) 
Peptide nucleic acid (PNA) was described originally by Nielsen et al. as a DNA analogue 
where the phosphodiester backbone is replaced by a pseudo-peptide (90,91). PNA has an 
efficient discrimination of single-base mismatches, forming the basis for the development of 
diagnostic applications to identify polymorphisms (92-94). Originally, PNA was designed to 
bind DNA as a TFO aiming to control transcription (95). Table 3 summarizes the different 
modes of PNA interactions with dsDNA. A remarkable idea was the development of the first 
ON with two arms able to form both WC and HG bonding, named bisPNA (96), features later 
replicated, and further developed, using LNA (80). PNA was shown to form various 
complexes, which have higher thermal stability under moderate ionic strengths compared to 
unmodified nucleic acids (97). However, PNA-RNA duplexes can not be cleaved by 
RNaseH, which is a disadvantage when used in antisense strategies (98). Conversely, PNA 
has different advantages over other nucleic acid modifications, being extremely resistant to 
nuclease degradation, showing poor or no binding to serum proteins and also being stable 
against protease activity (91). PNA can pass slowly by passive diffusion through cell 
membranes, which can be due to the neutral charge backbone (99). An antisense effect by 
PNA has been reported in primary neurons (100), and PNA has been injected in vivo in 
different ways, intracerebral (101), intrathecal (102) and intraventricular (103) causing 
biological effects in rats. 
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Figure 4. Chemical structures of DNA and peptide nucleic acid (PNA). 
Table 3. Binding modes that generate double strand invasion 
Binding 
mode 
Schematic illustration Mechanism of binding 
Demonstrated 
LNA PNA 
Duplex 
invasion 
 
A linear ON bind to the sense-
strand by WC.  
The antisense-strand is 
displaced.  
(80,87) (104) 
Triplex 
invasion 
 
Two separate ONs, one binding 
by HG and the other by WC; both 
ONs target the sense strand. The 
antisense-strand is displaced. 
 (80,87) (96) 
Double 
duplex 
invasion   
Pair of ONs with “weak bases” 
that cannot hybridize to each 
other, binds by WC to the sense 
and anti-sense strand of dsDNA 
(also known as 
pseudocomplementary).  
- (105) 
Clamp 
invasion  
The two arms are linked. The 
TFO-arm binds by HG to the 
sense-strand, while the WC-arm 
invades the duplex forming new 
WC bonds with the TFO-targeted 
strand.                          The 
antisense-strand is displaced. 
(81) (106) 
Tail 
clamp 
invasion  
(80,81) (107) 
Zorro-
LNA 
invasion  
An ON binding simultaneously to 
both strands by WC. (83-85) - 
Pu, purine. Py, pyrimidine. TFO (yellow), polypurine strand (red), polypyrimidine strand (blue). 
() indicates HG hydrogen bonds and (I) indicates WC hydrogen bonds. 
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1.5 DNA MODE OF BINDING 
 Binding of small molecules to the DNA double helix has been studied in detail. The two 
common binding modes are intercalation and groove binding. Some of the methods for 
distinguishing between intercalation and grove binding modes were described by Suh et al. 
(108). 
1.5.1 Intercalators 
DNA intercalation changes the structure of the double helix, and causes lengthening, 
stiffening and unwinding (109-111). Zeglis et al. defined intercalators as small organic 
molecules or metal complexes that unwind DNA in order to π-stack between two base pairs 
(112). π-stack interactions are non covalent (113,114), and are important in chemical and 
biological recognition (115). The study of intercalating chemical compounds is important as 
they are among the most promising therapeutic agents to treat many diseases (54,116-118); 
some of these molecules are approved by the FDA and used for the treatment of cancer, like 
Mitoxantrone that inhibits DNA synthesis by intercalating in DNA (119).  
The stability of triplex helix structures under physiological conditions can be potentiated by 
using chemically modified ONs, but also by the use of agents that bind specifically to triplex 
helices. Ethidium bromide is a classical duplex intercalator able also to intercalate in T.AxT 
(120) but not in C.GxC+ (121). However, Benzopyridoindole derivatives (BPI) can stabilize 
triplex C.GxC+ and bind preferentially to triplex as compared to duplex (122). Other 
compounds have been described with the capacity to intercalate into triplexes, agents such as 
coralyne (123), sanguinarine (124), benzophenazine (125), benzophenanthridine (126) and 
tricyclic amidoanthraquinones (127) among others. In this thesis we focused on 
benzoquinoquinoxaline and twisted intercalating nucleic acid compounds. 
1.5.1.1 Benzoquinoquinoxaline (BQQ)   
Benzoquinoquinoxaline (BQQ) is a triple helix-intercalating compound, able to bind 
specifically and stabilize triplex structures of purine and pyrimidine motifs (128-131). BQQ 
is a low-molecular weight compound and has been shown to enter cells, bind and stabilize 
intra-molecular triplexes (H-DNA) (132,133). When BQQ is conjugated to neomycin it also 
intercalates into triple-helical DNA (134). Other uses of BQQ are related to DNA labeling by 
using electron or optical microscopy (135,136), and for gene delivery by plasmid 
modification (137). BQQ inhibits the enzymatic cleavage (138), and blocks the transcription 
by RNA polymerase (139). In this thesis we used BQQ to probe for triplex formation of the 
different complexes analyzed. 
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Moreover, BQQ has been converted to a triplex-specific cleaving agent when conjugated to 
EDTA (140) or to a 1,10-phenanthroline derivate (130). 
1.5.1.2 Twisted intercalating nucleic acid (TINA) 
Twisted intercalating nucleic acid (TINA) is an intercalator covalently joined and inserted 
into ONs (141). TINA is a modification derived from an intercalating nucleic acid (INA), 
used as a bulge insertion to stabilize duplex DNA, but having the opposite effect in triplexes, 
decreasing their stability (142). TINA contains an aromatic group to stack with the bases 
allowing stabilization of ON binding. TINA discriminates between triplex and duplex DNA, 
and increases the thermal stability of parallel triplexes (143,144). There are two variants of 
TINA (145): (i) ortho-TINA (o-TINA) designed to stabilize WC antiparallel DNA duplexes 
and (ii) para-TINA (p-TINA) designed to stabilize HG triplexes and quadruplexes.  
 
Figure 5. Chemical structures of benzoquinoquinoxaline (BQQ) and para-twisted 
intercalating nucleic acid (p-TINA). 
1.5.2 Groove binders 
In contrast to intercalation, groove binding only causes a subtle change to the double helix 
(109-111). Nucleic acid binding within the major groove of the DNA is rare, but is common 
for DNA-binding proteins (below section). Two adjacent base pairs must be separated to 
create a binding pocket for the ligand, this is a requirement for binding (109).  
Binding to the minor groove does not require a big distortion of the DNA. The majority of 
minor groove binders has four structural characteristics, positive charge, curvature, flexibility 
and hydrogen bond donor and acceptor groups (146). A good example of minor groove 
binder is the antibiotic netropsin, that binds selectively to AT-rich sequences in the minor 
groove of DNA (147,148). The main focus in this thesis is in major groove binders. 
1.6 DNA BINDING PROTEINS 
The ability that specific proteins have to bind selectively to a particular DNA region in the 
genome is the basis for the transcriptional regulatory pathways (149). DNA-binding proteins 
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are very important in biology and are responsible for replicating the genome, controlling gene 
expression and repairing damaged DNA (150). Transcription factors (TFs) are one of the 
groups of DNA-binding proteins. There are approximately 12 to 15 structurally distinct 
DNA-binding domains known from eukaryotic transcription factors (151). Some of them are 
the helix-turn-helix, Zn binding domains, the leucine-zipper coiled coil, β-ribbon proteins, 
among others (152). 
1.6.1 The leucine-zipper coiled coil  
Known also as leucine-zipper bZIP, this domain consists of an α-helix with leucines on the 
same side of the helix, every seven amino acids. A leucine residue is found at the fourth 
position of four of five successive heptads in the activator protein GCN4 (General Control 
Nonderepressible 4) (153). The yeast transcriptional activator GCN4 is one of over 30 
identified eukaryotic proteins containing the basic region leucine zipper (bZIP) DNA-binding 
motif (154) (bZIP GCN4). The crystal structure is available at the Protein Data Bank (PDB-
ID:1YSA) 2.9 Å resolution.  
 
Figure 6. Crystal structure of bZIP GCN4. 
1.7 GENE THERAPY 
In 1972 it was suggested that “in the future” gene therapy could be used as a treatment for 
human genetic diseases (155). Since then significant events have occurred, as the design of a 
retrovirus vector to efficiently insert foreign genes into mammalian chromosomes (156), the 
first successful clinical trial by using a retroviral system for a severe immune system 
deficiency (adenosine deaminase, ADA) (157), and the use of gene transfer into 
hematopoietic stem cells for correcting of human severe combined immunodeficiency 
(SCID)-X1 disease (158). More than that, in 2003 China approved Gendicine, the world’s 
first commercial gene therapy that delivers p53 using an adenoviral vector for the treatment 
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of head and neck squamous cell carcinoma (159). After that was demonstrated that a 
lentiviral containing a sequence complementary to a miRNA can be used to control 
transgene expression (160) and genetically engineered cells (peripheral blood lymphocytes 
(PBLs)) can be used for cancer immunotherapy (161). Currently, according to the Journal of 
Gene Medicine there are in the world 1357 clinical trials in phase I and 994 in other trials, 
what is a probe of the big progress in gene therapy approaches. For more details in clinical 
trials (see review (162)). 
1.8 THE ANTI-GENE STRATEGY 
Anti-gene strategy is the approach of gene therapy for control the gene expression at the 
transcriptional level based on the sequence specificity (163). TFOs are potential tools to 
control by inhibition of the transcription the gene expression in a sequence specific manner 
(46,47), what can be used as anti-gene strategy. The first successful example of in vitro 
inhibition of the transcription was reported by using a 27-base-long DNA oligonucleotide 
targeting the c-MYC gene (164). The triplex anti-gene approach has been investigated in other 
proto-oncogenes like ki-ras (165), bcl-2 (166), her-2 (167), c-met (168) and TFOs have been 
used to interfere with functions of the replicative cycle of HIV (169,170). TFOs have the 
possibly to be used also as an antisense strategy. By for example, blocking RNA processing 
(171), reverse transcription (172) and translation.  
Binding sites for TFOs in the human genome, or triple-helix target sites (TTS), are abundant 
especially in promoter regions (173,174), which make that TFOs can potentially be exploited 
in anti-gene strategies for the therapy of cancers and other genetic diseases. Lately, different 
tools have been developed that facilitate the analysis and search of TTS in the genome, 
including algorithms (175) (176) and TFO databases (177), non-B DNA structures databases 
(178) and web-service tools (179,180) have been established. Together with the Encyclopedia 
of DNA Elements (181,182) these resources can help to select the best TTS to target with 
TFOs. 
1.9 MOLECULAR DYNAMICS 
In 1977 was published the first molecular dynamics (MD) simulation for proteins (183); since 
then MD has become an important tool to understand the structure, physics and functions of 
macromolecules (184). Comparison between simulation and experimental results is a way to 
validate the data and to improve the methodology (185,186). Simulation methods can be 
applied to macromolecules for determining or understanding better structures obtained from 
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experimental results; describe systems in equilibrium and their thermodynamical parameters; 
and to examine actual dynamics. In this thesis we used MD in an integrated way to suggest 
experimental studies and to analyze and extend the interpretations of the experimental data on 
ON interactions with DNA. 
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2 AIMS 
 
I. To investigate and map the bisLNA binding to a supercoiled duplex DNA. (Paper I) 
II. To evaluate parameters influencing triplex formation and extend these observations to 
elucidate the molecular mechanism of bisLNA binding to a dsDNA. (Paper II - 
Submitted manuscript) 
III. To evaluate the binding of peptides used as dsDNA binding, synthetic transcription 
factor mimics. (Paper III) 
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3 METHODOLOGY 
 
This section covers some relevant methods used in the present thesis. 
3.1 RADIOLABELING 
Radioactive end labeling can be used for visualizing and allowing the detection of nucleic 
acids at low concentrations. DNA, RNA and modified nucleic acids can be radiolabelled. 
Even when safer non-radioactive levels are available the sensitive detection of radioactive 
label is the “gold standard” of probe technology (187). In this thesis the primers (paper I), 
and the pyrimidine or purine strand of the DNA (paper II and III) was labeled using [γ-32P] 
ATP and T4 polynucleotide kinase and purified using a Nucleotide Removal Kit. The 
kinase catalyzes the transfer of the ATP γ-phosphate to the 5’-hydroxyl terminal end of the 
DNA (188).  
3.2 ELECTROPHORETIC MOBILITY SHIFT ASSAY (EMSA)  
Electrophoretic mobility shift assay was originally developed as a method to detect protein-
DNA interactions (189,190). Currently, EMSA has been used also to detect different types 
of interactions between ligands (DNA, RNA, proteins) and DNA (191). After 
electrophoresis, the different complexes containing nucleic acid are determined, usually by 
autoradiography of 32P-labeled nucleic acid. In this thesis (paper II and paper III) we used 
EMSA to detect ONs (TFO and bisLNA) or peptide interactions with their target sequence. 
Due to the rate of DNA migration in the gel a shifted band can be detected; the shifted band 
corresponds to the complexes formed that migrate more slowly compared to the free DNA. 
EMSA allows the quantification and identification of complexes formed between a ligand 
and their target. EMSA can be used also to study binding affinities and thermodynamic and 
kinetics parameters (189,190). PAGE gels have a better resolution than the less toxic 
agarose gels.  
3.3 FOOTPRINTING 
Footprinting is a method that allows identifying sequence-specific interactions of drugs, 
proteins (192,193), nucleic acids like e.g. TFOs (194,195), and DNA intercalators (196) 
with a DNA target; and can be used to determine the sequence selectivity, affinity and 
kinetics of DNA-binding ligands (197). Originally the method was used for DNA-protein 
interactions (198). If a ligand such as a TFO is bound to a DNA target site, this region is 
then protected from cleavage by DNase I or S1 nuclease and from chemical modification 
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using for example chloroacetaldehyde (CAA). For clamp constructs, like bisLNA, the 
displaced strand in the targeted dsDNA is susceptible to CAA chemical modification, , as 
was described in paper (I). To examine the binding site of the ligand, primer extension 
reaction is carried out using the modified DNA strand as a template (199). 
3.4 CHLOROACETALDEHYDE (CAA) REACTION 
Chloroacetaldehyde (CAA) reacts with the exocyclic amino group of cytosine and adenine 
residues preferentially in single-stranded regions of nucleic acids (200). After the CAA 
reaction, the modified DNA single strand regions are more susceptible to alkali cleavage 
(201). Single strand DNA chemical modification using CAA was used in paper (I) to map, 
at one nucleotide resolution, the site of the displaced strand, which showed bisLNA binding 
to the DNA target sequence. 
3.5 PRIMER EXTENSION (PE) 
Primer extension is basically a PCR performed with only one primer, which was used in 
paper (I). By primer extension the complementary primer binds to the specific region of the 
single stranded template and Taq polymerase and dNTPs were used to synthesize the 
complementary DNA strand. The primers are radiolabeled with [γ-32P] ATP and the PE 
products are analyzed using polyacrylamide gel electrophoresis (PAGE). Radioactivity is the 
more common labeling method for footprinting (202,203). Currently, other possibilities to 
detect the "footprint" include fluorescently labeled primers analyzed by capillary 
electrophoresis avoiding the risk of exposition to radiation (81,204). 
3.6 S1 NUCLEASE DIGESTION 
S1 is an enzyme able to cleave single stranded DNA/RNA, but not double strand DNA or 
RNA/DNA. S1 has been used to open genomic regions like hairpins (205), inverted repeats 
(206), promoter regions (207) and to detect strand invasion in the case of PNA (202), bisPNA 
(203), Zorro-LNA (84) and for the study of triplexes in vivo (208-210). When bisLNA strand 
invades it is possible to use S1 to cleave the single strand that is displaced. It acts as a probe 
of the strand invasion and it is possible to determine the efficiency of the duplex 
invasion/hybridization of the ON by quantifying the amount of supercoiled and nicked 
plasmid. S1 was used to verify DSI by bisLNA in paper (I). 
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4 RESULTS AND DISCUSSION 
PAPER 1 
Development of bis-locked nucleic acid (bisLNA) oligonucleotides for efficient invasion 
of supercoiled duplex DNA 
The main aim of this paper was to demonstrate the capacity of LNA to achieve duplex 
invasion of supercoiled DNA under intranuclear salt and pH conditions, by using a designed 
clamp-type construct. 
Previous work in our group using the LNA technology was done, with the aim to develop a 
construct with the potential to sequence-specifically invade dsDNA and block gene 
expression, a construct called zorro-LNA. This construct was able to simultaneously bind to 
both the coding strand of DNA and to the template strand showing double-strand invasion  
(DSI); furthermore, Zorro-LNA was able to block both RNA-polymerase II and RNA-
polymerase III (83,84).  
We observed that zorro-LNAs were able to bind only to a supercoiled plasmid, but not to a 
linearized plasmid. We therefore decided to explore a new strategy using two modes of 
binding to DNA, the triplex formation and WC-mediated DSI, based on a clamp-type 
construct that previously demonstrated efficiency using PNA oligomers. In this paper, with 
the aim of developing a construct with the potential to specifically block gene expression in a 
genomic context, the bisLNA construct was developed.  
BisLNA ONs are single strand mixed LNA-DNA ONs designed for strand-invasion of 
duplex DNA (DSI), with the ability to bind to the double helix via both HG and WC 
interactions. The bisLNA sequence is composed of nucleotides or nucleic acid analogues, and 
the structure consists of two arms and one flexible non-complementary linker. Both arms of 
the bisLNAs, that were used in this thesis, bind to DNA polypurine sequences, where one 
arm forms Hoogsteen hydrogen bonds to the polypurine target strand as a TFO, whereas the 
other arm binds through DSI of the double helix, forming Watson-Crick hydrogen bonds and 
displacing the opposite strand. The TFO-part subsequently forms a new triplex with the 
ensuing LNA-DNA duplex. This mode of binding results in an extremely stable complex, but 
has so far not been reported to arrest transcription in vivo. However, TFO binding requires 
special sequences with only purines in the target strand, while the DSI-part does not suffer 
from any restriction. Thus, extending this part outside the polypurine target site to form a 
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“tail-clamp” construct was an option, which possibly could become an important asset for 
efficient biological targeting.   
As LNA, in contrast to PNA, had not been previously used in clamp constructs, the first 
assays were oriented to perform this evaluation. In order to do that, a 25-mer ON with 10 
bases in each arm and a 5 nt linker was used (bisLNA20). A plasmid containing six bisLNA 
binding sites was used as a target for the bisLNA20 a,b,c,d and e. The incubation was 
performed in acidic pH (5.8) in order to favour triplex formation. After the incubation, the 
hybridization products (plasmid+bisLNA) were analysed by fluorescence. According to the 
results, only the clamp construct containing LNA could efficiently invade the DNA, in 
contrast to all the other constructs lacking LNA. This was an initial proof demonstrating that 
LNA is also able to invade dsDNA. This evaluation was possible thanks to that the ONs were 
Cy3 or Cy5 labelled.  
The constructs (TFO, WC, TFO+WC and bisLNA20) were evaluated by gel electrophoresis. 
As was expected, the signal of the clamp construct (bisLNA20) was more intensive than the 
signal from the TFO+WC separately, and TFO and WC did not show any binding. These 
results were confirmed by using the S1 nuclease assay generating single strand DNA 
cleavage. Thus, the S1 cleavage is a quantitative evaluation of the DSI. The results confirmed 
the previous conclusion.  
Next we evaluated the influence of each arm in the clamp construct and how the effect of the 
presence or absence of LNA. Here we studied two new constructs with different LNA content 
in one of the arms (TFO or WC). Our results indicate that having 50% LNA-substitution in 
each arm of the bisLNA is crucial for efficient DSI. 
To probe for bisLNA binding of DNA in nearly physiological salt and pH conditions, the 
incubation reactions were carried out at pH 7.4, 37°C with intranuclear salt conditions. 
Different experiments were performed to optimize the bisLNA constructs under these 
conditions. Influence of the length of each arm on bisLNA binding to a single site was 
examined using different bisLNAs with short TFO arm, short WC and long WC-arm. We 
observed that shortening the WC-arm causes a negative effect in the DSI when as compared 
to a bisLNA construct that has the WC-arm extended (tail). In addition, when bisLNA that 
has short TFO (3nt-shorter) was compared with the bisLNA control (m44), no significant 
effect was observed. Here we also conclude that bisLNA tail clamp constructs were more 
efficient in DSI than clamp type. 
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Next, we aimed to evaluate the bisLNA binding to a single site and a new plasmid was used, 
which contained the full c-MYC promoter sequence and a binding site for the bisLNA. We 
examined plasmid DNA binding of a bisLNA (m44) with a tail (WC-arm extended, 29nt) and 
15nt TFO arm, which was incubated for 72h, and we achieved nearly 80% DSI. This was 
compared with the results obtained in the presence of bisLNAm30 (15-mer), which showed 
less than 5% of DSI. 
To provide evidence for the degree of DSI, footprinting was performed. This allows mapping 
of the DNA single strand regions that result from bisLNA invasion by the WC-arm binding. 
A plasmid containing a single binding site for the bisLNA in the c-MYC promoter region was 
used. The plasmid was incubated in the presence or absence of bisLNAm44 or the WC-arm 
separately. After 72h, the DSI was evaluated by EMSA. The samples were treated with 
chloroacetaldehyde (CAA). CAA can react with the cytosines, adenines and some guanines 
of the single strand, which was followed by a cleavage reaction under alkaline conditions. 
Primer extension reaction with radiolabeled primers was performed to detect the modified 
DNA sites. ddNTPs were used for the synthesis of the four different sequence ladders.  We 
observed that the samples treated with CAA, showed a strong signal (as judged from the 
intensities of the gel bands) in the region that corresponds to the bisLNA binding site. The 
CAA reaction was enhanced in the DNA sample treated with bisLNA as compared to the 
corresponding DNA in the presence o the WC-LNA ON. The results of the described 
chemical probing provide a proof for the following conclusions: bisLNA invasion is highly 
sequence specific, both WC-LNA arm and bisLNA can invade double-strand DNA, but 
bisLNA is more efficient, and finally bisLNAs is able to invade dsDNA at intra-nuclear pH 
and salt conditions. Therefore, bisLNA is a new efficient clamp type ON, being an alternative 
to bisPNA, which primarily works under non-physiological, ‘low salt’ conditions.  
 
PAPER 2 
LNA effects on DNA binding and conformation: from single strand to duplex and triplex 
structures 
The main aim of this paper was to better understand the underlying structural features of 
LNA containing ONs starting from single to duplex and triplex structures.  
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Here we investigated the role of the position and number of locked nucleic acid (LNA) 
substitutions in the ON and the effect of TINA at three different positions of the TFO (5’end, 
middle and 3’-end). 
In the previous paper, the bisLNA, WC-arm was evaluated extensively and also the DSI. 
However not much information was available about the TFO-arm and triplex formation. With 
this curiosity we started to evaluate TFOs and triplex formation. Here we used the same 
target sequence and we began by using the TFO-arm (15-mer) of the bisLNA that we 
previously evaluated by chemical probing. 
Molecular modeling (MD) simulations was used to confirm mostly all our experimental 
results and also provided new conformation-based information. The TFO was evaluated by 
EMSA using a short, radioactively labeled target sequence. All the binding experiments were 
performed in parallel in the presence of BQQ, as a probe for triplex formation. LNA 
substitution was evaluated using different TFOs. With the purpose to better understand the 
triplex formation, shorter and longer incubation times were used. Also different ratios 
TFO:dsDNA were studied to optimize triplex formation with regards to TFO concentration. 
First, we examined dsDNA binding of a TFO containing LNA or non-modified DNA. We 
showed that the TFO lacking LNA was unable to form triplex, demonstrating the impact of 
LNA substitution in TFOs. Second, we evaluated the importance of the Cy3 labeled and the 
end position (5’-end) of the TFO starting with an LNA instead of DNA. According to our 
results we could see that triplex formation takes at least 24h when using the lowest ratio of 
DNA:TFO (1:12). Also, we found that the TFO labeled with Cy3 was less efficient compared 
with the unlabeled; which is important to point out since the use of fluorescently labeled ONs 
is quite common in several cell-based assays.  
Then, we decided to evaluate the importance of the LNA position in the TFO. For this, we 
studied a set of TFOs with less LNA at one of the ends. The 3’ position was the most 
important for LNA substitution, which could be potentially explained by the mechanism of 
TFO binding.   
To further improve triplex formation, we decided to introduce an intercalating agent in the 
TFO. The TINA intercalator was placed at the ends or in the middle of the TFO. The first 
observation was the dramatic effect of TINA on triplex formation. After one hour at a 
DNA:TFO ratio of 1:100, 100% triplex formation was achieved. This shows the effect of 
TINA and the importance of the 3’-end position, which was consistent when using the 
corresponding shorter TFOs  
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Moreover, we used a duplex target sequence including a DNA-LNA pyrimidine strand, thus 
constituting a hetero-duplex target. We compared TFO binding to the homoduplex and 
heteroduplex targets and we found that triplex formation was faster with the hetero-duplex 
sequence. We found that LNA-substitutions in the WC pyrimidine strand alter the 
conformation of the duplex, which forms an intermediate of A/B-type DNA. This 
conformation is observed after the TFO is bound to both DNA homo-duplexes and to hetero-
duplexes, where one of the strands is a DNA-LNA mixmer. Such hetero-duplexes are formed 
when bisLNAs (80,211) invade into homo-duplex DNA, and this information helps to 
understand the mechanism of bisLNA invasion.  
Finally, we also evaluated the mechanism of bisLNA binding. For this, binding of the TFO, 
WC and bisLNA to the dsDNA target were examined in parallel. Taken together we believe 
that different DNA complexes are formed during bisLNA binding with triplex formation as 
the first event followed by double strand invasion.  
 
PAPER 3 
Sequence-selective DNA recognition and enhanced cellular up-take by peptide-steroid 
conjugates 
Currently, a strategy in development for cancer therapy is the use of sequence-specific DNA 
binders based on peptide-steroid conjugates. A requirement for that is that the peptides have 
to be able to penetrate the membrane and reach to the nucleus. In the evaluated peptides the 
basic DNA binding region of the GCN4 protein has a positive charge due to the six arginine 
residues, similar to various cell-penetrating peptides, something that might help to enter into 
the cell. The transcription factor protein GCN4, belongs to the bZIP Leucine Zipper family. 
This paper is part of our cooperation with Gent University. The peptides were synthetized by 
the substitution of the Leucine zipper domain of the protein by a deoxycholic acid derivative 
of the two GCN4 binding region peptides. Four peptides were evaluated. For the peptides 
number 8 and 10 no binding was detected. However peptide 7 and 9 showed a high affinity 
for the CRE target sequence. Peptide 7, shows higher binding affinity compared with peptide 
9. However, with the first EMSA results it was not possible to calculate the KD because not 
so many concentrations were available to make the calculations. This is a really good 
indication that the peptide has a high affinity for the target. To proceed with the analysis we 
decreased the concentration of the peptides and we included a DNA competitor with the 
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purpose to eliminate the possibility of unspecific binding. When the DNA competitor 
(500nM) was added a better-shifted result was observed. Even under this condition peptide 7 
continued being the best compared with 8 and the specificity to the sequence is high, as can 
be seem for the gradual shifted band opposite to the first EMSA analysis without the DNA 
competitor. When the KD was calculated, peptide 7 had the lowest KD compared with 
peptide 9, what can be interpreted as a decent specificity. Peptide 7 has a longer and more 
flexible linker that allows the construct to grip the major groove of the DNA and that could 
explain the better binder capacity 
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5 CONCLUDING REMARKS AND FUTURE PERSPECTIVE 
 
BisLNA is an ON with seemingly great potential for DSI under physiological conditions. However, a 
limitation could be size, due to the long tail. One alternative to potentiate and optimize the bisLNA 
can be the use of other modifications. Some of these modifications have been already evaluated in the 
bisLNA report published in 2016. In this paper was probed that bis-m44-gly-M3 that contains a 
stacking linker M3 and glyLNAs was better invader to DNA and with maintained 
specificity. In the analysis of this optimized bisLNA a footprinting assay was also 
performed but without the use of radiolabeling, instead of that capillary electrophoresis and 
fluorescent primer were used, thus avoiding the use of radioactive labeling. Introduction of 
more than one M3 intercalator had favorable effects on tail-less bisLNAs and future 
research on intercalator positioning may identify the optimal positioning of these. 
Some of the TFOs that were evaluated in paper II were directed to pyrimidine regions, 
providing information about the design of TFOs to target these regions. Moreover, poly-
purine regions are highly prevalent, especially in promoter regions. We have already started 
some studies, not included in this thesis. The new designs include the use of 
pseudoisocytidine to overcome the problem of the cytosine protonation with the aim of 
obtaining good TFO binding a pH 7.4.  
Another, possibility to improve the bisLNA design is to study in more detail the effect of 
the WC-arm and one possibility is using the same model that we evaluated in paper II, 
where we have a hetero-duplex target sequence. In this case we also have preliminary 
indications that the position and amount of LNA in the WC of this type of design could be 
crucial to improve the bisLNA technology. 
Peptides are an alternative option to target DNA. As shown in paper II, some of the designs 
are promising and have demonstrated effects in cell culture. We have also carried out 
experiments with other chemistries that we evaluated by EMSA and follow-up studies will 
include the evaluation of their activity in cell cultures. 
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